Credit: Huy Mach, Washington University
Charles Hoy (left), a patient with acute myeloid leukemia (AML), talks with his medical oncologist, Rizwan Romee, MD, of Washington University School of Medicine in St. Louis. Romee co-leads clinical trials evaluating a new immunotherapy against AML. Hoy is receiving an investigational treatment that harnesses the immune system's "natural killer" cells, putting them through a training period in the lab to help them attack leukemia cells in the blood.